Alector, Inc.
Overview
Alector, Inc. is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative diseases and rare diseases caused by immune dysfunction. The company's proprietary technology leverages immuno-neurology to treat diseases such as Alzheimer's and Parkinson's.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Alector, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Alector, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.